Status:
TERMINATED
Treatment of Elderly Subjects With Psychosis and Behavioral Disturbances Associated With Dementia of the Alzheimer's Type
Lead Sponsor:
Solvay Pharmaceuticals
Conditions:
Psychosis and Behavioral Disturbances Associated With Dementia of the Alzheimer's Type
Eligibility:
All Genders
65-90 years
Phase:
PHASE3
Brief Summary
This is a 10-week study with bifeprunox and placebo in elderly subjects with psychosis and behavioral disturbances associated with dementia of the alzheimer's type.
Eligibility Criteria
Inclusion
- Diagnosis of dementia of the Alzheimer's type
Exclusion
- History of seizure disorder
- Clinically significant electrocardiogram (ECG)
- Clinical or radiological evidence of stroke, vascular dementia or dementia due to substance abuse, or head trauma
Key Trial Info
Start Date :
December 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2008
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT00160147
Start Date
December 1 2005
End Date
January 1 2008
Last Update
February 9 2015
Active Locations (51)
Enter a location and click search to find clinical trials sorted by distance.
1
Site 912
Phoenix, Arizona, United States
2
Site 902
Carson, California, United States
3
Site 903
Long Beach, California, United States
4
Site 911
Pasadena, California, United States